Targeted Radiotherapy With Submyeloablative Doses of 131I-MIBG Is Effective for Disease Palliation in Highly Refractory NeuroblastomaTammy I. Kang, John M. Maris, Mark Hickeson et al.|Journal of Pediatric Hematology/Oncology|2003Cited by 64